Author:
Menon Rajeev M.,Polepally Akshanth R.,Khatri Amit,Awni Walid M.,Dutta Sandeep
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference42 articles.
1. Pilot-Matias T, Tripathi R, Cohen D, Gaultier I, Dekhtyar T, Lu L, et al. In vitro and in vivo antiviral activity and resistance profile of the hepatitis C virus NS3/4A protease inhibitor ABT-450. Antimicrob Agents Chemother. 2015;59(2):988–97.
2. Bow DAJ, Liu J, Kavetskaia O, Menon R, de Morais SM, Nijsen M. A mechanistic nonclinical assessment of drug-drug interactions (metabolism and transporters) with the hepatitis C virus (HCV) regimen: ABT-450/r, ombitasvir and dasabuvir. New York: AASLD/EASL Special Conference on Hepatitis C; 2014.
3. Hirsch MS, Gunthard HF, Schapiro JM, Brun-Vezinet F, Clotet B, Hammer SM, et al. Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. Clin Infect Dis. 2008;47(2):266–85.
4. Badri PS, Shuster DL, Dutta S, Menon RM. Clinical pharmacokinetics of ombitasvir. Clin Pharmacokinet. doi:
10.1007/s40262-017-0518-4
.
5. King JR, Zha J, Khatri A, Dutta S, Menon RM. Clinical pharmacokinetics of dasabuvir. Clin Pharmacokinet. doi:
10.1007/s40262-017-0519-3
.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献